TABLE 4. Values for Healthy and Pre-Treatment Groups.
| VRQOL |  |
 |
Jit(%) | |
|---|---|---|---|---|
| Females median/median absolute deviation | ||||
| N01 #48–49 | 100/0 | 98.5/4.5 | 919/184 | 0.145/0.04 |
| FD01 #210–242 | 70/15 | 90/5.5 | 551/118 | 0.200/0.08 |
| FD23 #178–207 | 57/17 | 85/6 | 437/101 | 0.380/0.23 |
| Males median/median absolute deviation | ||||
| N01 #49–50 | 100/0 | 97.5/6.5 | 686/116.5 | 0.09/0.02 |
| FD01 #106–129 | 77/15 | 92/5 | 366/89 | 0.130/0.06 |
| FD23 #74–93 | 67/15 | 87.5/5.5 | 330/97 | 0.290/0.20 |
Median and median absolute deviation of all healthy and pre-treatment groups. The range ”#x-#y” denotes the number of available samples that were minimally and maximally available for the parameters.